Journal of geriatric oncologyHumansLymphomaLarge B-CellDiffuseAged
Retrospective analysis of treatment patterns and outcomes in older adults with diffuse large B-cell lymphoma in the Veterans Health Administration.
Supreet Kaur, Heidi Latiolais, Michael Mader, Kathleen Franklin, Zohra Nooruddin
Published: 202510.1016/j.jgo.2025.102772
Abstract
INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is the most prevalent subtype of non-Hodgkin lymphoma (NHL), accounting for 31% of NHL cases in Western populations with a median diagnosis age of 70.4 years. Despite the efficacy of standard treatm…
Preview only. Read the full abstract at the source